Effects of Mycotoxins on Child Development
1Child Development, Faculty of Health Sciences, Cankiri Karatekin University, Cankiri, Turkey.
Current Molecular Pharmacology
|December 15, 2020
Summary
Mycotoxins negatively impact child development from prenatal stages through adolescence. Exposure can lead to low birth weight, developmental delays, immune system damage, and cognitive issues in children.
Area of Science:
- Toxicology
- Pediatrics
- Developmental Biology
Background:
- Mycotoxins, toxic metabolites produced by fungi, pose significant health risks.
- Children are particularly vulnerable due to immature systems and developmental processes.
- Mycotoxin exposure can affect the immune system, leading to various health issues.
Purpose of the Study:
- To examine the detrimental effects of mycotoxins on child development.
- To synthesize findings from existing literature on mycotoxin impacts on children.
- To highlight the critical developmental periods affected by mycotoxin exposure.
Main Methods:
- Document analysis of research articles and accessible books.
- Literature search conducted on Google Scholar from 2002 to 2020.
- Comprehensive review and synthesis of collected studies.
Main Results:
- Prenatal exposure is linked to increased low birth weight, growth retardation, congenital anomalies, and neural tube defects.
- Infant exposure can cause developmental retardation, immune system damage, gastrointestinal problems, and cognitive deficits.
- Childhood and adolescent exposure may result in developmental delays, neurological problems, and academic failures.
Conclusions:
- Mycotoxin exposure presents a serious threat to all stages of child development.
- Early and continued exposure can lead to lifelong health and developmental consequences.
- Further research and preventative measures are crucial to mitigate these risks.
Related Concept Videos
01:36Types of Toxins
2.9K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.9K
01:26Toxic Reactions: Overview
1.6K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.6K
01:07Teratogenicity
3.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.7K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
90
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
90
01:28Disorders of the Nervous Tissue
2.3K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.3K
01:25Mutagenicity and Carcinogenicity
1.7K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.7K